TERAZOSIN HYDROCHLORIDE
| Brand name | TEZRULY |
|---|---|
| Active ingredient | TERAZOSIN HYDROCHLORIDE |
| Strength | EQ 1MG BASE/ML |
| Dosage form | SOLUTION |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | July 2024 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 12427108 | February 2041 | product |
| 11224572 | February 2041 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.